ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

TELA vs XTNT // EV/EBITDA & P/E VALUATION

TELA Bio Inc. (NASDAQ) VS. Xtant Medical Holdings Inc. (NYSE) • 15-METRIC TALLY: TELA 3 — XTNT 5
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TELA VS. XTNT) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC TELA XTNT SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 67.70% 62.90% +4.80 TELA /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% 12.80% -47.80 XTNT /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — 3.7x — TIE /valuation <GO>
Free Cash Flow Yield — 24.95% — TIE /fcf-yield <GO>
Operating Margin -42.00% 5.40% -47.40 XTNT /operating-margins <GO>
Net Profit Margin -48.30% 0.00% -48.30 XTNT /net-margins <GO>
Revenue Growth (YoY) 15.80% 14.20% +1.60 TELA /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 0.20 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 4/9 9/9 -5.00 XTNT /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 33.8 34.9 -1.16 XTNT /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $41.5M $40.7M $792.3K TELA /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR TELA REV XTNT REV TELA GROSS % XTNT GROSS % TELA FCF XTNT FCF
FY 2025 $80.3M $133.9M 67.7% 62.9% -$28.7M $10.2M
FY 2024 $69.3M $117.3M 67.1% 58.2% -$42.6M -$16.0M
FY 2023 $58.5M $91.3M — — -$40.9M -$9.5M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TELA // BETA —
XTNT // BETA —